var data={"title":"Epidemiology and etiology of premenopausal osteoporosis","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Epidemiology and etiology of premenopausal osteoporosis</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/contributors\" class=\"contributor contributor_credentials\">Carolyn B Becker, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/contributors\" class=\"contributor contributor_credentials\">Adi Cohen, MD, MHS</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/contributors\" class=\"contributor contributor_credentials\">Clifford J Rosen, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/contributors\" class=\"contributor contributor_credentials\">Jean E Mulder, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Feb 06, 2018.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Osteoporosis is a skeletal condition characterized by low bone mass, which is associated with reduced bone strength and an increased risk of fractures. Osteoporosis occurs most commonly in postmenopausal women. Numerous guidelines and recommendations exist regarding the evaluation and management of osteoporosis in this population. Male osteoporosis has also gained attention as a growing public health concern. Postmenopausal osteoporosis and osteoporosis in men are reviewed separately. (See <a href=\"topic.htm?path=clinical-manifestations-diagnosis-and-evaluation-of-osteoporosis-in-postmenopausal-women\" class=\"medical medical_review\">&quot;Clinical manifestations, diagnosis, and evaluation of osteoporosis in postmenopausal women&quot;</a> and <a href=\"topic.htm?path=overview-of-the-management-of-osteoporosis-in-postmenopausal-women\" class=\"medical medical_review\">&quot;Overview of the management of osteoporosis in postmenopausal women&quot;</a> and <a href=\"topic.htm?path=epidemiology-and-etiology-of-osteoporosis-in-men\" class=\"medical medical_review\">&quot;Epidemiology and etiology of osteoporosis in men&quot;</a>.)</p><p>Both fractures and low bone mass are less common in premenopausal women. Low bone mass, when present, may be related to either inadequate peak bone mass acquisition <span class=\"nowrap\">and/or</span> ongoing bone loss. Bone loss <span class=\"nowrap\">and/or</span> fractures can often be attributed to a secondary cause such as estrogen deficiency, glucocorticoid exposure, or hyperparathyroidism. The term idiopathic osteoporosis is reserved for the subset of women with no apparent etiology or known secondary cause.</p><p>The diagnosis of osteoporosis and guidelines for treatment of osteoporosis based upon bone mass in postmenopausal women do not generally apply to premenopausal women, as the relationship between bone mass and fracture risk in premenopausal women is not the same as in postmenopausal women.</p><p>This topic reviews the definition, epidemiology, and etiology of premenopausal osteoporosis. Evaluation and management will be reviewed separately. (See <a href=\"topic.htm?path=evaluation-and-treatment-of-premenopausal-osteoporosis\" class=\"medical medical_review\">&quot;Evaluation and treatment of premenopausal osteoporosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">DEFINITIONS</span></p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h2\">Low bone mass</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The measurement of bone mineral density (BMD) by dual-energy x-ray absorptiometry (DXA) is used as an index of bone strength and fracture risk, and it can be used to diagnose osteoporosis in some populations, such as postmenopausal women. The World Health Organization (WHO) defines osteoporosis in postmenopausal women as a BMD value at the spine, hip, or forearm of 2.5 or more standard deviations (SD) below the young adult mean (T-score &le;-2.5), with or without the presence of a fragility fracture [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/1\" class=\"abstract_t\">1</a>]. (See <a href=\"topic.htm?path=clinical-manifestations-diagnosis-and-evaluation-of-osteoporosis-in-postmenopausal-women\" class=\"medical medical_review\">&quot;Clinical manifestations, diagnosis, and evaluation of osteoporosis in postmenopausal women&quot;</a> and <a href=\"topic.htm?path=overview-of-dual-energy-x-ray-absorptiometry\" class=\"medical medical_review\">&quot;Overview of dual-energy x-ray absorptiometry&quot;</a>.)</p><p>In premenopausal women, the prevalence of fractures is much lower compared with postmenopausal women, and the relationship between BMD and fracture risk is not the same. Thus, neither the diagnostic guidelines nor the treatment practices based on BMD measurements in postmenopausal women can apply to this younger population. Similarly, the Fracture Risk Assessment (FRAX) tool cannot be used to evaluate fracture risk based on BMD in premenopausal women. The International Society for Clinical Densitometry (ISCD) recommends use of BMD Z-scores (comparison with age-matched norms) at the lumbar spine, total hip, femoral neck, and distal radius, rather than T-scores, and avoidance of the term osteopenia [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/2\" class=\"abstract_t\">2</a>]. The use of Z-scores in this population helps to avoid application of the postmenopausal diagnostic and therapeutic implications of the T-score. A Z-score &le;-2.0 should be interpreted as &quot;below the expected range for age&quot; [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/2\" class=\"abstract_t\">2</a>]. (See <a href=\"topic.htm?path=clinical-manifestations-diagnosis-and-evaluation-of-osteoporosis-in-postmenopausal-women\" class=\"medical medical_review\">&quot;Clinical manifestations, diagnosis, and evaluation of osteoporosis in postmenopausal women&quot;</a> and <a href=\"topic.htm?path=overview-of-dual-energy-x-ray-absorptiometry\" class=\"medical medical_review\">&quot;Overview of dual-energy x-ray absorptiometry&quot;</a>.)</p><p>BMD measurements alone should not be used to define osteoporosis in premenopausal women [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/3\" class=\"abstract_t\">3</a>]. According to the ISCD, a young woman with low BMD for age (Z-score &le;-2.0) and with risk factors for fracture or secondary causes of osteoporosis (such as glucocorticoid therapy, hypogonadism, or hyperparathyroidism) may be defined as having premenopausal osteoporosis [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/2\" class=\"abstract_t\">2</a>]. However, in contrast to ISCD, the International Osteoporosis Foundation (IOF) recommends use of T-scores in those aged 20 to 50 years and suggests use of T-score &lt;-2.5 to define osteoporosis, particularly in those with known secondary causes or in the context of low-trauma fractures that provide evidence of bone fragility [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/4\" class=\"abstract_t\">4</a>]. We continue to use and recommend the ISCD definitions.</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h2\">Low-trauma fracture</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Premenopausal women may come to medical attention because of a fragility fracture. As in all cases of unusual fracture, the diagnosis of osteoporosis should be considered only after osteomalacia (undermineralization due to causes such as severe vitamin D deficiency or hypophosphatemia) and other causes of pathological fracture (eg, malignancy, avascular necrosis, fibrous dysplasia, other bone lesion) have been ruled out. After ruling out these pathologies, any fracture in an adult woman (aside from a fracture of the digits, skull, or face) that occurs from a standing height or less, without major trauma such as a motor vehicle accident, can be considered a low-trauma or fragility fracture. Such women may have decreased bone strength and may be considered to have osteoporosis, irrespective of BMD.</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h1\">EPIDEMIOLOGY</span></p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h2\">Low bone mass</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Low bone mass is less common in premenopausal women compared with postmenopausal women and, when present, may be related to either inadequate peak bone mass acquisition, or previous or continuing bone loss.</p><p>The clinical significance of isolated low bone density (without fracture) in young women is unknown. Some premenopausal women with low bone mineral density (BMD), particularly those with a known secondary cause of osteoporosis, may have abnormal bone strength that may lead to an increased risk of fracture. Currently, available data do not allow us to predict fracture risk in premenopausal women with low bone density and no known secondary cause. One longitudinal study has documented stable BMD and a low short-term risk of fractures in this population [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/5\" class=\"abstract_t\">5</a>]. However, in a study of premenopausal women with idiopathic osteoporosis (unexplained low BMD or low-trauma fracture), high-resolution peripheral quantitative computed tomography (HRpQCT) [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/6\" class=\"abstract_t\">6</a>] and analyses of transiliac biopsy samples [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/7\" class=\"abstract_t\">7</a>] showed comparable microarchitectural deterioration in the low BMD and fracture groups compared with controls [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/6\" class=\"abstract_t\">6</a>].</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h3\">Peak bone mass acquisition</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>BMD in premenopausal women depends primarily upon achievement of peak bone mass. Low BMD in a premenopausal woman may result from the attainment of a peak bone mass that is below average due to genetic predisposition, illnesses, or medications that negatively impact bone density accrual. &quot;Peak bone mass&quot; is usually defined as the maximum BMD achieved by age 40 years, as measured by dual-energy x-ray absorptiometry (DXA) [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/8\" class=\"abstract_t\">8</a>].</p><p>In healthy girls, the peak period of bone mass accrual occurs between ages 11 and 14 years [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/9\" class=\"abstract_t\">9</a>]. Although 95 to 100 percent of peak bone mass is acquired by the late teen years [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/9-11\" class=\"abstract_t\">9-11</a>], studies have documented continued small gains occurring between the ages of 20 and 29 years [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/12\" class=\"abstract_t\">12</a>]. Population-based, cross-sectional studies suggest that women attain peak bone mass at the proximal femur in their 20s and at the spine and forearm around age 30 years [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/13,14\" class=\"abstract_t\">13,14</a>].</p><p>Attainment of peak bone mass varies according to gender, ethnicity, body size, and region of bone. As an example, Chinese American women appear to attain peak bone mass at a later age [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/15\" class=\"abstract_t\">15</a>]. Thus, when interpreting BMD measurements in premenopausal women, the possibility that peak bone mass has not yet been achieved must always be considered. (See <a href=\"topic.htm?path=pathogenesis-of-osteoporosis#H341616\" class=\"medical medical_review\">&quot;Pathogenesis of osteoporosis&quot;, section on 'Peak bone mass acquisition'</a>.)</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h3\">Perimenopausal bone loss</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Bone loss begins prior to menopause, as illustrated by several prospective studies [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/16-25\" class=\"abstract_t\">16-25</a>] that have reported varying degrees of bone loss during the menopausal transition, more often in women with subclinical ovulation disturbances or perimenopausal symptoms [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/26,27\" class=\"abstract_t\">26,27</a>].</p><p>In a longitudinal, multiethnic cohort study of 862 women followed for 10 years, the annual rates and cumulative amounts of BMD loss were greater one year prior through two years after the final menstrual period (transmenopause) than those occurring between two and five years after the final menstrual period (postmenopause) [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/28\" class=\"abstract_t\">28</a>]. Cumulative 10-year and transmenopause BMD loss was 10.6 and 7.4 percent, respectively, at the lumbar spine and 9.1 and 5.8 percent, respectively, at the femoral neck. Higher body mass index (BMI) and African American ancestry were associated with slower bone loss. The adverse effect of low body weight on bone loss during the menopausal transition was similarly reported in a study of 896 perimenopausal women followed for a mean of six years [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/29\" class=\"abstract_t\">29</a>].</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h2\">Fractures</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Premenopausal women generally have much lower rates of fracture than postmenopausal women [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/30-34\" class=\"abstract_t\">30-34</a>]. As in postmenopausal women, however, young women with lower BMD tend to have the greatest risk for fractures [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/35-37\" class=\"abstract_t\">35-37</a>]. In two studies of premenopausal women with Colles' fractures, BMD at the nonfractured radius [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/38\" class=\"abstract_t\">38</a>], lumbar spine, and femoral neck [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/39\" class=\"abstract_t\">39</a>] were significantly below age-matched peers. In another study comparing premenopausal women with a distal radius fracture with controls, BMD (DXA) was similar at these sites; however, there was evidence of trabecular microarchitectural deterioration (as measured by HRpQCT) at both the distal radius and distal tibia in the women with fracture [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/40\" class=\"abstract_t\">40</a>]. Stress fractures, particularly common among certain groups of young women including professional ballet dancers, military recruits, and female athletes, are sometimes associated with lower BMD [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/41-49\" class=\"abstract_t\">41-49</a>]. Studies using analyses of images obtained via HRpQCT of the radius and tibia have also documented trabecular microarchitectural deficiencies in premenopausal women with fractures, in comparison with controls [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/50-52\" class=\"abstract_t\">50-52</a>]. (See <a href=\"topic.htm?path=overview-of-stress-fractures\" class=\"medical medical_review\">&quot;Overview of stress fractures&quot;</a> and <a href=\"topic.htm?path=functional-hypothalamic-amenorrhea-pathophysiology-and-clinical-manifestations\" class=\"medical medical_review\">&quot;Functional hypothalamic amenorrhea: Pathophysiology and clinical manifestations&quot;</a>.)</p><p>Vertebral fractures can occur despite normal BMD in women receiving glucocorticoids. One study found that 7 of 16 premenopausal women treated with high-dose glucocorticoids had evidence of vertebral fractures despite normal BMD [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/53\" class=\"abstract_t\">53</a>]. Vertebral fractures in premenopausal women may go undetected unless radiographs or vertebral assessment measurements are performed. In certain high-risk populations, such as young women with autoimmune disorders on high doses of glucocorticoids, the prevalence of vertebral fractures may be as high as 21 percent [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/54\" class=\"abstract_t\">54</a>].</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h3\">Later risk</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A history of premenopausal fracture significantly increases the risk of a postmenopausal fracture. Data from the Study of Osteoporotic Fractures (SOF) demonstrate that women with a history of premenopausal fracture are 35 percent more likely to fracture during the postmenopausal years compared with women without a history of premenopausal fracture [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/32\" class=\"abstract_t\">32</a>]. This relationship persists after controlling for a number of potential confounding variables. Other studies have reported similar findings [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/32,33,55,56\" class=\"abstract_t\">32,33,55,56</a>]. These findings suggest that the risk of sustaining fractures may be a lifelong trait, probably reflecting the interaction of an individual's bone mass, bone quality, fall frequency, and neuromuscular protective response to falls [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/33\" class=\"abstract_t\">33</a>].</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h1\">ETIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In premenopausal women, low bone mass <span class=\"nowrap\">and/or</span> low-trauma fractures can sometimes be attributed to a secondary cause such as estrogen deficiency, glucocorticoid exposure, or hyperparathyroidism (<a href=\"image.htm?imageKey=ENDO%2F64403\" class=\"graphic graphic_table graphicRef64403 \">table 1</a>).</p><p>Low bone mass may be related to either inadequate peak bone mass acquisition <span class=\"nowrap\">and/or</span> ongoing bone loss. Premenopausal women with low bone mass, no history of adult fracture, and no known secondary cause may or may not have a defect in bone strength.</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h2\">Premenopausal bone loss</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A number of factors influence the rate and degree of premenopausal bone loss including age, weight changes, body mass index (BMI), calcium and vitamin D intake, physical activity, alcohol consumption, family history of osteoporosis, smoking, and number of pregnancies [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/29,57-59\" class=\"abstract_t\">29,57-59</a>]. Two reports suggest that among late perimenopausal women, rising follicle-stimulating hormone (FSH) levels are most predictive of bone loss from the spine and hip [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/17,60\" class=\"abstract_t\">17,60</a>].</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h2\">Secondary causes</span></p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h3\">Estrogen deficiency</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Premenopausal estrogen deficiency from any cause is associated with bone loss or inadequate peak bone mass accrual. Examples include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hypogonadotropic hypogonadism due to low weight, eating disorders, excessive exercise, hyperprolactinemia, and hypopituitarism. (See <a href=\"topic.htm?path=functional-hypothalamic-amenorrhea-pathophysiology-and-clinical-manifestations\" class=\"medical medical_review\">&quot;Functional hypothalamic amenorrhea: Pathophysiology and clinical manifestations&quot;</a> and <a href=\"topic.htm?path=eating-disorders-overview-of-epidemiology-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Eating disorders: Overview of epidemiology, clinical features, and diagnosis&quot;</a> and <a href=\"topic.htm?path=clinical-manifestations-and-evaluation-of-hyperprolactinemia\" class=\"medical medical_review\">&quot;Clinical manifestations and evaluation of hyperprolactinemia&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hypergonadotropic hypogonadism (premature ovarian failure) is associated with bone loss if estrogen is not replaced. Women with Turner syndrome may have an additional selective reduction in bone mineral density (BMD) that is independent of estrogen exposure. (See <a href=\"topic.htm?path=management-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\" class=\"medical medical_review\">&quot;Management of spontaneous primary ovarian insufficiency (premature ovarian failure)&quot;</a> and <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-turner-syndrome#H14\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of Turner syndrome&quot;, section on 'Osteoporosis and bone health'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In premenopausal women with breast cancer, chemotherapy often results in premature ovarian failure and, as a result, estrogen deficiency and bone loss. Because these women are not candidates for estrogen therapy, other treatment strategies are necessary. (See <a href=\"topic.htm?path=evaluation-and-treatment-of-premenopausal-osteoporosis\" class=\"medical medical_review\">&quot;Evaluation and treatment of premenopausal osteoporosis&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H15\"><span class=\"h3\">Drugs</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Drugs that may be associated with bone loss in premenopausal women include glucocorticoids, anticonvulsants, antidepressants, and depot <a href=\"topic.htm?path=medroxyprogesterone-acetate-drug-information\" class=\"drug drug_general\">medroxyprogesterone acetate</a>. (See <a href=\"topic.htm?path=clinical-features-and-evaluation-of-glucocorticoid-induced-osteoporosis\" class=\"medical medical_review\">&quot;Clinical features and evaluation of glucocorticoid-induced osteoporosis&quot;</a> and <a href=\"topic.htm?path=drugs-that-affect-bone-metabolism\" class=\"medical medical_review\">&quot;Drugs that affect bone metabolism&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H16\"><span class=\"h3\">Other</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Many of the other risk factors for premenopausal osteoporosis are similar to those for postmenopausal osteoporosis and osteoporosis in men, including (<a href=\"image.htm?imageKey=ENDO%2F64403\" class=\"graphic graphic_table graphicRef64403 \">table 1</a>):</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cigarette smoking.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Inflammatory bowel disease. (See <a href=\"topic.htm?path=metabolic-bone-disease-in-inflammatory-bowel-disease\" class=\"medical medical_review\">&quot;Metabolic bone disease in inflammatory bowel disease&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Celiac disease. (See <a href=\"topic.htm?path=pathogenesis-epidemiology-and-clinical-manifestations-of-celiac-disease-in-adults#H21\" class=\"medical medical_review\">&quot;Pathogenesis, epidemiology, and clinical manifestations of celiac disease in adults&quot;, section on 'Metabolic bone disease'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cystic fibrosis. (See <a href=\"topic.htm?path=cystic-fibrosis-clinical-manifestations-and-diagnosis#H14\" class=\"medical medical_review\">&quot;Cystic fibrosis: Clinical manifestations and diagnosis&quot;, section on 'Musculoskeletal disorders'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Previous or current hyperthyroidism. (See <a href=\"topic.htm?path=bone-disease-with-hyperthyroidism-and-thyroid-hormone-therapy\" class=\"medical medical_review\">&quot;Bone disease with hyperthyroidism and thyroid hormone therapy&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hypercalciuria [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/61\" class=\"abstract_t\">61</a>]. (See <a href=\"topic.htm?path=risk-factors-for-calcium-stones-in-adults\" class=\"medical medical_review\">&quot;Risk factors for calcium stones in adults&quot;</a>.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hyperparathyroidism. (See <a href=\"topic.htm?path=primary-hyperparathyroidism-clinical-manifestations#H9\" class=\"medical medical_review\">&quot;Primary hyperparathyroidism: Clinical manifestations&quot;, section on 'Bone mineral density'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Osteogenesis imperfecta. (See <a href=\"topic.htm?path=osteogenesis-imperfecta-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Osteogenesis imperfecta: Clinical features and diagnosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Depression has been associated with low BMD in premenopausal women [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/62-64\" class=\"abstract_t\">62-64</a>]. However, the relationship between depression and osteoporosis is likely complex. Individuals with depression tend to have other risk factors for low bone mass, including medication use (antidepressants), hypercortisolism, and lifestyle factors (smoking, alcohol, physical inactivity).</p><p/><p class=\"headingAnchor\" id=\"H17\"><span class=\"h2\">Normal pregnancy and lactation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Some studies suggest that pregnancy is associated with bone losses of approximately 3 to 5 percent at the spine and hip [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/65-67\" class=\"abstract_t\">65-67</a>], while other studies have found that bone density remains stable during this period of increased calcium demand [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/68\" class=\"abstract_t\">68</a>], or declines significantly only at the trochanter [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/69\" class=\"abstract_t\">69</a>].</p><p>In contrast, lactation has more consistent and profound effects on bone density [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/70\" class=\"abstract_t\">70</a>]. Bone loss of 3 to 10 percent at the spine and hip are seen over three to six months of lactation [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/67,71\" class=\"abstract_t\">67,71</a>]. Bone loss is related to duration of lactation and duration of amenorrhea and is not prevented by calcium supplementation [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/72-74\" class=\"abstract_t\">72-74</a>].</p><p>Parathyroid hormone-related protein (PTHrP), which is secreted by the lactating mammary gland, plays an important role in the control of calcium mobilization from bone during lactation in both humans and animals [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/70,75,76\" class=\"abstract_t\">70,75,76</a>]. Circulating calcitonin [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/77\" class=\"abstract_t\">77</a>] and the estrogen deficiency that is characteristic of lactation may also be involved in the control of bone loss during this time.</p><p>Bone loss reverses during and after weaning, but the regulators mediating bone recovery in this setting have not been clearly defined [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/78\" class=\"abstract_t\">78</a>]. Longitudinal studies in postpartum women show that recovery from lactation-associated bone loss may continue for 18 months or longer [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/73,79\" class=\"abstract_t\">73,79</a>]. Studies in both humans and animal models suggest that the pattern and extent of bone recovery may be site specific, with complete reversal at the spine but incomplete or slower recovery at other sites [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/80\" class=\"abstract_t\">80</a>]. Of note, most studies have not found an association between either parity (number of births) or lactation and osteoporosis or increased fracture risk in postmenopausal women in the United States or northern Europe [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/81-83\" class=\"abstract_t\">81-83</a>].</p><p>These reproduction-related changes affect interpretation of bone density results. Care must be taken to obtain a detailed history regarding recent pregnancies and duration of lactation when interpreting bone density in a parous premenopausal woman. When bone density measurements are obtained around the time of pregnancy or lactation, it may be difficult to separate physiologic from pathophysiologic changes.</p><p class=\"headingAnchor\" id=\"H18\"><span class=\"h2\">Pregnancy and lactation-associated osteoporosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pregnancy and lactation-associated osteoporosis (PLO) is a rare condition in which women typically present with fractures, often vertebral, in the third trimester of pregnancy or in the early postpartum period [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/84,85\" class=\"abstract_t\">84,85</a>].</p><p>Skeletal fragility in these cases may result from abnormal pregnancy-related changes in bone. Alternatively, women with preexisting skeletal fragility may manifest with fractures in the setting of the skeletal stress associated with a pregnancy [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/86,87\" class=\"abstract_t\">86,87</a>]. An investigation of first-degree relatives of patients with PLO has suggested a strong genetic component [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/88\" class=\"abstract_t\">88</a>]. A case-control study comparing over 100 women with PLO with controls documented more frequent childhood dental issues and lower childhood physical activity in those with PLO [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/89\" class=\"abstract_t\">89</a>].</p><p>A longitudinal study reported increases in spine and hip BMD over several years after the index pregnancy in women not receiving bone-specific therapy [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/90\" class=\"abstract_t\">90</a>]. However, in another study, in which 109 women with PLO were followed for a median of six years, fracture recurred in 24 percent overall and in 20 percent within the context of another pregnancy. Fracture recurrence risk was significantly correlated with the number of fractures at the time of diagnosis [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/91\" class=\"abstract_t\">91</a>].</p><p>As this disorder is likely to be heterogeneous in its etiology and prognosis, a thorough evaluation for secondary causes of osteoporosis should be undertaken in all cases of PLO. Treatment decisions must be approached on a case-by-case basis.</p><p class=\"headingAnchor\" id=\"H19\"><span class=\"h2\">Transient osteoporosis of the hip</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Transient osteoporosis of the hip (TOH) is a separate, rare skeletal disorder that can occur in men and women, but it often occurs in previously healthy women during the third trimester of pregnancy [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/92\" class=\"abstract_t\">92</a>]. In these cases, women present with unilateral or bilateral hip pain without prior trauma. Magnetic resonance imaging (MRI) may show marrow edema of the femoral head and neck that is distinct from avascular necrosis [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/93\" class=\"abstract_t\">93</a>]. Radiographs may show regional demineralization approximately one month after the presentation with pain symptoms. While some pregnant women develop femoral fractures related to TOH, others have resolution of hip pain over an average of six months postpartum without the development of fractures [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/94\" class=\"abstract_t\">94</a>].</p><p>The etiology of this condition is unknown, but it may be related to pelvic nerve compression, vascular insufficiency, or fibrinolytic system changes with pregnancy [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/94\" class=\"abstract_t\">94</a>]. Because of the favorable prognosis, treatment is usually supportive and conservative [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/95\" class=\"abstract_t\">95</a>].</p><p class=\"headingAnchor\" id=\"H20\"><span class=\"h2\">Idiopathic osteoporosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Young women with bone fragility who lack secondary causes and disturbances in calcium metabolism are said to have &quot;idiopathic osteoporosis&quot; (IOP). This is likely to be a heterogeneous disorder. Proposed mechanisms include osteoblast dysfunction, abnormalities in the growth hormone <span class=\"nowrap\">(GH)/insulin-like</span> growth factor-1 (IGF-1) axis, subclinical estrogen deficiency, and increased bone turnover [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/7,61,96-101\" class=\"abstract_t\">7,61,96-101</a>]. In a report of bone biopsy samples from women with IOP, bone remodeling was heterogeneous, with high, normal, and low bone formation rates seen [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/7\" class=\"abstract_t\">7</a>]. Among the women studied, those with the lowest bone formation rate had the most profound microarchitectural abnormalities.</p><p>Two reports of idiopathic osteoporosis described the following clinical features [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/61,96\" class=\"abstract_t\">61,96</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Men and women were affected equally.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Caucasians were affected more than other races.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A family history of osteoporosis was common.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The mean age at diagnosis was approximately 35 years old.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Fractures were usually multiple, occurring over a 5- to 10-year period, and involving sites rich in cancellous bone, such as the vertebrae. The hip was affected in approximately 10 percent of cases.</p><p/><p class=\"headingAnchor\" id=\"H1531222098\"><span class=\"h1\">SOCIETY GUIDELINE LINKS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See <a href=\"topic.htm?path=society-guideline-links-osteoporosis\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Osteoporosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H21\"><span class=\"h1\">SUMMARY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The relationship between fracture and low bone mass in premenopausal women is less certain than in postmenopausal women. Thus, the bone mineral density (BMD) criteria for diagnosis of osteoporosis in postmenopausal women do not generally apply to premenopausal women. (See <a href=\"#H2\" class=\"local\">'Definitions'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Low bone mass in premenopausal women may be due to suboptimal peak bone mass acquisition, ongoing bone loss, or both. The clinical significance of isolated low bone density in young women is unknown. (See <a href=\"#H5\" class=\"local\">'Epidemiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Low bone mass <span class=\"nowrap\">and/or</span> low-trauma fractures are usually attributable to other conditions that predispose to osteoporosis (as in men and postmenopausal women). Premenopausal estrogen deficiency and pregnancy and lactation-associated osteoporosis (PLO) are unique to younger women. (See <a href=\"#H13\" class=\"local\">'Secondary causes'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A history of fracture in a premenopausal woman is associated with an increased risk of fracture later in life. (See <a href=\"#H10\" class=\"local\">'Later risk'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/1\" class=\"nounderline abstract_t\">Kanis JA, Melton LJ 3rd, Christiansen C, et al. The diagnosis of osteoporosis. J Bone Miner Res 1994; 9:1137.</a></li><li class=\"breakAll\">2013 ISCE Official Positions - Adult http://www.iscd.org/official-positions/2013-iscd-official-positions-adult/ (Accessed on October 31, 2013).</li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/3\" class=\"nounderline abstract_t\">Cosman F, de Beur SJ, LeBoff MS, et al. Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int 2014; 25:2359.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/4\" class=\"nounderline abstract_t\">Ferrari S, Bianchi ML, Eisman JA, et al. Osteoporosis in young adults: pathophysiology, diagnosis, and management. Osteoporos Int 2012; 23:2735.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/5\" class=\"nounderline abstract_t\">Peris P, Monegal A, Mart&iacute;nez MA, et al. Bone mineral density evolution in young premenopausal women with idiopathic osteoporosis. Clin Rheumatol 2007; 26:958.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/6\" class=\"nounderline abstract_t\">Cohen A, Liu XS, Stein EM, et al. Bone microarchitecture and stiffness in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab 2009; 94:4351.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/7\" class=\"nounderline abstract_t\">Cohen A, Dempster DW, Recker RR, et al. Abnormal bone microarchitecture and evidence of osteoblast dysfunction in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab 2011; 96:3095.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/8\" class=\"nounderline abstract_t\">Mora S, Gilsanz V. Establishment of peak bone mass. Endocrinol Metab Clin North Am 2003; 32:39.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/9\" class=\"nounderline abstract_t\">Theintz G, Buchs B, Rizzoli R, et al. Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects. J Clin Endocrinol Metab 1992; 75:1060.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/10\" class=\"nounderline abstract_t\">Bachrach LK, Hastie T, Wang MC, et al. Bone mineral acquisition in healthy Asian, Hispanic, black, and Caucasian youth: a longitudinal study. J Clin Endocrinol Metab 1999; 84:4702.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/11\" class=\"nounderline abstract_t\">Baxter-Jones AD, Faulkner RA, Forwood MR, et al. Bone mineral accrual from 8 to 30 years of age: an estimation of peak bone mass. J Bone Miner Res 2011; 26:1729.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/12\" class=\"nounderline abstract_t\">Recker RR, Davies KM, Hinders SM, et al. Bone gain in young adult women. JAMA 1992; 268:2403.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/13\" class=\"nounderline abstract_t\">Tenenhouse A, Joseph L, Kreiger N, et al. Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int 2000; 11:897.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/14\" class=\"nounderline abstract_t\">L&ouml;fman O, Larsson L, Toss G. Bone mineral density in diagnosis of osteoporosis: reference population, definition of peak bone mass, and measured site determine prevalence. J Clin Densitom 2000; 3:177.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/15\" class=\"nounderline abstract_t\">Walker MD, Babbar R, Opotowsky AR, et al. A referent bone mineral density database for Chinese American women. Osteoporos Int 2006; 17:878.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/16\" class=\"nounderline abstract_t\">Mein AL, Briffa NK, Dhaliwal SS, Price RI. Lifestyle influences on 9-year changes in BMD in young women. J Bone Miner Res 2004; 19:1092.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/17\" class=\"nounderline abstract_t\">Sowers MR, Jannausch M, McConnell D, et al. Hormone predictors of bone mineral density changes during the menopausal transition. J Clin Endocrinol Metab 2006; 91:1261.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/18\" class=\"nounderline abstract_t\">Bainbridge KE, Sowers MF, Crutchfield M, et al. Natural history of bone loss over 6 years among premenopausal and early postmenopausal women. Am J Epidemiol 2002; 156:410.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/19\" class=\"nounderline abstract_t\">Melton LJ 3rd, Atkinson EJ, O'Connor MK, et al. Determinants of bone loss from the femoral neck in women of different ages. J Bone Miner Res 2000; 15:24.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/20\" class=\"nounderline abstract_t\">Chapurlat RD, Garnero P, Sornay-Rendu E, et al. Longitudinal study of bone loss in pre- and perimenopausal women: evidence for bone loss in perimenopausal women. Osteoporos Int 2000; 11:493.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/21\" class=\"nounderline abstract_t\">Sowers M, Crutchfield M, Bandekar R, et al. Bone mineral density and its change in pre-and perimenopausal white women: the Michigan Bone Health Study. J Bone Miner Res 1998; 13:1134.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/22\" class=\"nounderline abstract_t\">Slemenda C, Longcope C, Peacock M, et al. Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri-, and postmenopausal women. J Clin Invest 1996; 97:14.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/23\" class=\"nounderline abstract_t\">Berger C, Langsetmo L, Joseph L, et al. Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents. CMAJ 2008; 178:1660.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/24\" class=\"nounderline abstract_t\">Finkelstein JS, Brockwell SE, Mehta V, et al. Bone mineral density changes during the menopause transition in a multiethnic cohort of women. J Clin Endocrinol Metab 2008; 93:861.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/25\" class=\"nounderline abstract_t\">Sowers MR, Zheng H, Jannausch ML, et al. Amount of bone loss in relation to time around the final menstrual period and follicle-stimulating hormone staging of the transmenopause. J Clin Endocrinol Metab 2010; 95:2155.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/26\" class=\"nounderline abstract_t\">Iki M, Morita A, Ikeda Y, et al. Biochemical markers of bone turnover predict bone loss in perimenopausal women but not in postmenopausal women-the Japanese Population-based Osteoporosis (JPOS) Cohort Study. Osteoporos Int 2006; 17:1086.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/27\" class=\"nounderline abstract_t\">Seifert-Klauss V, Link T, Heumann C, et al. Influence of pattern of menopausal transition on the amount of trabecular bone loss. Results from a 6-year prospective longitudinal study. Maturitas 2006; 55:317.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/28\" class=\"nounderline abstract_t\">Greendale GA, Sowers M, Han W, et al. Bone mineral density loss in relation to the final menstrual period in a multiethnic cohort: results from the Study of Women's Health Across the Nation (SWAN). J Bone Miner Res 2012; 27:111.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/29\" class=\"nounderline abstract_t\">Macdonald HM, New SA, Campbell MK, Reid DM. Influence of weight and weight change on bone loss in perimenopausal and early postmenopausal Scottish women. Osteoporos Int 2005; 16:163.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/30\" class=\"nounderline abstract_t\">Thompson PW, Taylor J, Dawson A. The annual incidence and seasonal variation of fractures of the distal radius in men and women over 25 years in Dorset, UK. Injury 2004; 35:462.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/31\" class=\"nounderline abstract_t\">Melton LJ 3rd, Amadio PC, Crowson CS, O'Fallon WM. Long-term trends in the incidence of distal forearm fractures. Osteoporos Int 1998; 8:341.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/32\" class=\"nounderline abstract_t\">Hosmer WD, Genant HK, Browner WS. Fractures before menopause: a red flag for physicians. Osteoporos Int 2002; 13:337.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/33\" class=\"nounderline abstract_t\">Wu F, Mason B, Horne A, et al. Fractures between the ages of 20 and 50 years increase women's risk of subsequent fractures. Arch Intern Med 2002; 162:33.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/34\" class=\"nounderline abstract_t\">Hsu YH, Venners SA, Terwedow HA, et al. Relation of body composition, fat mass, and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women. Am J Clin Nutr 2006; 83:146.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/35\" class=\"nounderline abstract_t\">Goulding A, Gold E, Walker R, Lewis-Barned N. Women with past history of bone fracture have low spinal bone density before menopause. N Z Med J 1997; 110:232.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/36\" class=\"nounderline abstract_t\">Fiorano-Charlier C, Ostertag A, Aquino JP, et al. Reduced bone mineral density in postmenopausal women self-reporting premenopausal wrist fractures. Bone 2002; 31:102.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/37\" class=\"nounderline abstract_t\">Lauder TD, Dixit S, Pezzin LE, et al. The relation between stress fractures and bone mineral density: evidence from active-duty Army women. Arch Phys Med Rehabil 2000; 81:73.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/38\" class=\"nounderline abstract_t\">Wigderowitz CA, Cunningham T, Rowley DI, et al. Peripheral bone mineral density in patients with distal radial fractures. J Bone Joint Surg Br 2003; 85:423.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/39\" class=\"nounderline abstract_t\">Hung LK, Wu HT, Leung PC, Qin L. Low BMD is a risk factor for low-energy Colles' fractures in women before and after menopause. Clin Orthop Relat Res 2005; :219.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/40\" class=\"nounderline abstract_t\">Rozental TD, Deschamps LN, Taylor A, et al. Premenopausal women with a distal radial fracture have deteriorated trabecular bone density and morphology compared with controls without a fracture. J Bone Joint Surg Am 2013; 95:633.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/41\" class=\"nounderline abstract_t\">Valentino R, Savastano S, Tommaselli AP, et al. The influence of intense ballet training on trabecular bone mass, hormone status, and gonadotropin structure in young women. J Clin Endocrinol Metab 2001; 86:4674.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/42\" class=\"nounderline abstract_t\">Warren MP, Brooks-Gunn J, Hamilton LH, et al. Scoliosis and fractures in young ballet dancers. Relation to delayed menarche and secondary amenorrhea. N Engl J Med 1986; 314:1348.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/43\" class=\"nounderline abstract_t\">Warren MP, Brooks-Gunn J, Fox RP, et al. Osteopenia in exercise-associated amenorrhea using ballet dancers as a model: a longitudinal study. J Clin Endocrinol Metab 2002; 87:3162.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/44\" class=\"nounderline abstract_t\">Kadel NJ, Teitz CC, Kronmal RA. Stress fractures in ballet dancers. Am J Sports Med 1992; 20:445.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/45\" class=\"nounderline abstract_t\">Gam A, Goldstein L, Karmon Y, et al. Comparison of stress fractures of male and female recruits during basic training in the Israeli anti-aircraft forces. Mil Med 2005; 170:710.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/46\" class=\"nounderline abstract_t\">Shaffer RA, Rauh MJ, Brodine SK, et al. Predictors of stress fracture susceptibility in young female recruits. Am J Sports Med 2006; 34:108.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/47\" class=\"nounderline abstract_t\">Lappe J, Davies K, Recker R, Heaney R. Quantitative ultrasound: use in screening for susceptibility to stress fractures in female army recruits. J Bone Miner Res 2005; 20:571.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/48\" class=\"nounderline abstract_t\">Joy EA, Campbell D. Stress fractures in the female athlete. Curr Sports Med Rep 2005; 4:323.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/49\" class=\"nounderline abstract_t\">Korpelainen R, Orava S, Karpakka J, et al. Risk factors for recurrent stress fractures in athletes. Am J Sports Med 2001; 29:304.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/50\" class=\"nounderline abstract_t\">Rozental TD, Johannesdottir F, Kempland KC, Bouxsein ML. Characterization of trabecular bone microstructure in premenopausal women with distal radius fractures. Osteoporos Int 2018; 29:409.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/51\" class=\"nounderline abstract_t\">Cohen A, Liu XS, Stein EM, et al. Bone microarchitecture and stiffness in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab 2009; 94:4351.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/52\" class=\"nounderline abstract_t\">Moreira CA, Bilezikian JP. Stress Fractures: Concepts and Therapeutics. J Clin Endocrinol Metab 2017; 102:525.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/53\" class=\"nounderline abstract_t\">Kumagai S, Kawano S, Atsumi T, et al. Vertebral fracture and bone mineral density in women receiving high dose glucocorticoids for treatment of autoimmune diseases. J Rheumatol 2005; 32:863.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/54\" class=\"nounderline abstract_t\">Borba VZ, Matos PG, da Silva Viana PR, et al. High prevalence of vertebral deformity in premenopausal systemic lupus erythematosus patients. Lupus 2005; 14:529.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/55\" class=\"nounderline abstract_t\">Honkanen R, Tuppurainen M, Kroger H, et al. Associations of early premenopausal fractures with subsequent fractures vary by sites and mechanisms of fractures. Calcif Tissue Int 1997; 60:327.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/56\" class=\"nounderline abstract_t\">Rothberg AD, Matshidze PK. Perimenopausal wrist fracture--an opportunity for prevention and management of osteoporosis. S Afr Med J 2000; 90:1121.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/57\" class=\"nounderline abstract_t\">Bainbridge KE, Sowers M, Lin X, Harlow SD. Risk factors for low bone mineral density and the 6-year rate of bone loss among premenopausal and perimenopausal women. Osteoporos Int 2004; 15:439.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/58\" class=\"nounderline abstract_t\">Adami S, Giannini S, Giorgino R, et al. Effect of age, weight and lifestyle factors on calcaneal quantitative ultrasound in premenopausal women: the ESOPO study. Calcif Tissue Int 2004; 74:317.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/59\" class=\"nounderline abstract_t\">Uusi-Rasi K, Siev&auml;nen H, Pasanen M, et al. Association of physical activity and calcium intake with the maintenance of bone mass in premenopausal women. Osteoporos Int 2002; 13:211.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/60\" class=\"nounderline abstract_t\">Sun L, Peng Y, Sharrow AC, et al. FSH directly regulates bone mass. Cell 2006; 125:247.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/61\" class=\"nounderline abstract_t\">Peris P, Gua&ntilde;abens N, Mart&iacute;nez de Osaba MJ, et al. Clinical characteristics and etiologic factors of premenopausal osteoporosis in a group of Spanish women. Semin Arthritis Rheum 2002; 32:64.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/62\" class=\"nounderline abstract_t\">Eskandari F, Martinez PE, Torvik S, et al. Low bone mass in premenopausal women with depression. Arch Intern Med 2007; 167:2329.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/63\" class=\"nounderline abstract_t\">Petronijevi&#263; M, Petronijevi&#263; N, Ivkovi&#263; M, et al. Low bone mineral density and high bone metabolism turnover in premenopausal women with unipolar depression. Bone 2008; 42:582.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/64\" class=\"nounderline abstract_t\">Altindag O, Altindag A, Asoglu M, et al. Relation of cortisol levels and bone mineral density among premenopausal women with major depression. Int J Clin Pract 2007; 61:416.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/65\" class=\"nounderline abstract_t\">Black AJ, Topping J, Durham B, et al. A detailed assessment of alterations in bone turnover, calcium homeostasis, and bone density in normal pregnancy. J Bone Miner Res 2000; 15:557.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/66\" class=\"nounderline abstract_t\">Naylor KE, Iqbal P, Fledelius C, et al. The effect of pregnancy on bone density and bone turnover. J Bone Miner Res 2000; 15:129.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/67\" class=\"nounderline abstract_t\">Karlsson MK, Ahlborg HG, Karlsson C. Maternity and bone mineral density. Acta Orthop 2005; 76:2.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/68\" class=\"nounderline abstract_t\">Sowers M, Crutchfield M, Jannausch M, et al. A prospective evaluation of bone mineral change in pregnancy. Obstet Gynecol 1991; 77:841.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/69\" class=\"nounderline abstract_t\">Kaur M, Pearson D, Godber I, et al. Longitudinal changes in bone mineral density during normal pregnancy. Bone 2003; 32:449.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/70\" class=\"nounderline abstract_t\">Kovacs CS. Maternal Mineral and Bone Metabolism During Pregnancy, Lactation, and Post-Weaning Recovery. Physiol Rev 2016; 96:449.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/71\" class=\"nounderline abstract_t\">Holmberg-Marttila D, Leino A, Siev&auml;nen H. Bone turnover markers during lactation, postpartum amenorrhea and resumption of menses. Osteoporos Int 2003; 14:103.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/72\" class=\"nounderline abstract_t\">Sowers M, Corton G, Shapiro B, et al. Changes in bone density with lactation. JAMA 1993; 269:3130.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/73\" class=\"nounderline abstract_t\">Kolthoff N, Eiken P, Kristensen B, Nielsen SP. Bone mineral changes during pregnancy and lactation: a longitudinal cohort study. Clin Sci (Lond) 1998; 94:405.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/74\" class=\"nounderline abstract_t\">Kalkwarf HJ, Specker BL, Bianchi DC, et al. The effect of calcium supplementation on bone density during lactation and after weaning. N Engl J Med 1997; 337:523.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/75\" class=\"nounderline abstract_t\">Sowers MF, Hollis BW, Shapiro B, et al. Elevated parathyroid hormone-related peptide associated with lactation and bone density loss. JAMA 1996; 276:549.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/76\" class=\"nounderline abstract_t\">VanHouten JN, Dann P, Stewart AF, et al. Mammary-specific deletion of parathyroid hormone-related protein preserves bone mass during lactation. J Clin Invest 2003; 112:1429.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/77\" class=\"nounderline abstract_t\">Woodrow JP, Sharpe CJ, Fudge NJ, et al. Calcitonin plays a critical role in regulating skeletal mineral metabolism during lactation. Endocrinology 2006; 147:4010.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/78\" class=\"nounderline abstract_t\">Wysolmerski JJ. Interactions between breast, bone, and brain regulate mineral and skeletal metabolism during lactation. Ann N Y Acad Sci 2010; 1192:161.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/79\" class=\"nounderline abstract_t\">Sowers M, Eyre D, Hollis BW, et al. Biochemical markers of bone turnover in lactating and nonlactating postpartum women. J Clin Endocrinol Metab 1995; 80:2210.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/80\" class=\"nounderline abstract_t\">Vajda EG, Bowman BM, Miller SC. Cancellous and cortical bone mechanical properties and tissue dynamics during pregnancy, lactation, and postlactation in the rat. Biol Reprod 2001; 65:689.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/81\" class=\"nounderline abstract_t\">Micha&euml;lsson K, Baron JA, Farahmand BY, Ljunghall S. Influence of parity and lactation on hip fracture risk. Am J Epidemiol 2001; 153:1166.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/82\" class=\"nounderline abstract_t\">Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 1995; 332:767.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/83\" class=\"nounderline abstract_t\">Alderman BW, Weiss NS, Daling JR, et al. Reproductive history and postmenopausal risk of hip and forearm fracture. Am J Epidemiol 1986; 124:262.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/84\" class=\"nounderline abstract_t\">Smith R, Athanasou NA, Ostlere SJ, Vipond SE. Pregnancy-associated osteoporosis. QJM 1995; 88:865.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/85\" class=\"nounderline abstract_t\">Kovacs CS, Ralston SH. Presentation and management of osteoporosis presenting in association with pregnancy or lactation. Osteoporos Int 2015; 26:2223.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/86\" class=\"nounderline abstract_t\">Heshmati HM, Khosla S. Idiopathic osteoporosis: a heterogeneous entity. Ann Med Interne (Paris) 1998; 149:77.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/87\" class=\"nounderline abstract_t\">Rizzoli R, Bonjour JP. Pregnancy-associated osteoporosis. Lancet 1996; 347:1274.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/88\" class=\"nounderline abstract_t\">Peris P, Gua&ntilde;abens N, Monegal A, et al. Pregnancy associated osteoporosis: the familial effect. Clin Exp Rheumatol 2002; 20:697.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/89\" class=\"nounderline abstract_t\">Hadji P, Boekhoff J, Hahn M, et al. Pregnancy-associated osteoporosis: a case-control study. Osteoporos Int 2017; 28:1393.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/90\" class=\"nounderline abstract_t\">Phillips AJ, Ostlere SJ, Smith R. Pregnancy-associated osteoporosis: does the skeleton recover? Osteoporos Int 2000; 11:449.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/91\" class=\"nounderline abstract_t\">Kyvernitakis I, Reuter TC, Hellmeyer L, et al. Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6&nbsp;years of follow-up. Osteoporos Int 2018; 29:135.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/92\" class=\"nounderline abstract_t\">Hadji P, Boekhoff J, Hahn M, et al. Pregnancy-associated transient osteoporosis of the hip: results of a case-control study. Arch Osteoporos 2017; 12:11.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/93\" class=\"nounderline abstract_t\">Malizos KN, Zibis AH, Dailiana Z, et al. MR imaging findings in transient osteoporosis of the hip. Eur J Radiol 2004; 50:238.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/94\" class=\"nounderline abstract_t\">Sweeney AT, Blake M, Holick MF. Transient osteoporosis of hip in pregnancy. J Clin Densitom 2000; 3:291.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/95\" class=\"nounderline abstract_t\">Samdani A, Lachmann E, Nagler W. Transient osteoporosis of the hip during pregnancy: a case report. Am J Phys Med Rehabil 1998; 77:153.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/96\" class=\"nounderline abstract_t\">Khosla S, Lufkin EG, Hodgson SF, et al. Epidemiology and clinical features of osteoporosis in young individuals. Bone 1994; 15:551.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/97\" class=\"nounderline abstract_t\">Reed BY, Zerwekh JE, Sakhaee K, et al. Serum IGF 1 is low and correlated with osteoblastic surface in idiopathic osteoporosis. J Bone Miner Res 1995; 10:1218.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/98\" class=\"nounderline abstract_t\">Pepene CE, Seck T, Diel I, et al. Concentration of insulin-like growth factor (IGF)-I in iliac crest bone matrix in premenopausal women with idiopathic osteoporosis. Exp Clin Endocrinol Diabetes 2004; 112:38.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/99\" class=\"nounderline abstract_t\">Rubin MR, Schussheim DH, Kulak CA, et al. Idiopathic osteoporosis in premenopausal women. Osteoporos Int 2005; 16:526.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/100\" class=\"nounderline abstract_t\">Peris P, Ruiz-Esquide V, Monegal A, et al. Idiopathic osteoporosis in premenopausal women. Clinical characteristics and bone remodelling abnormalities. Clin Exp Rheumatol 2008; 26:986.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis/abstract/101\" class=\"nounderline abstract_t\">Donovan MA, Dempster D, Zhou H, et al. Low bone formation in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab 2005; 90:3331.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 2058 Version 17.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H21\"><span>SUMMARY</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">DEFINITIONS</a><ul><li><a href=\"#H3\" id=\"outline-link-H3\">Low bone mass</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">Low-trauma fracture</a></li></ul></li><li><a href=\"#H5\" id=\"outline-link-H5\">EPIDEMIOLOGY</a><ul><li><a href=\"#H6\" id=\"outline-link-H6\">Low bone mass</a><ul><li><a href=\"#H7\" id=\"outline-link-H7\">- Peak bone mass acquisition</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">- Perimenopausal bone loss</a></li></ul></li><li><a href=\"#H9\" id=\"outline-link-H9\">Fractures</a><ul><li><a href=\"#H10\" id=\"outline-link-H10\">- Later risk</a></li></ul></li></ul></li><li><a href=\"#H11\" id=\"outline-link-H11\">ETIOLOGY</a><ul><li><a href=\"#H12\" id=\"outline-link-H12\">Premenopausal bone loss</a></li><li><a href=\"#H13\" id=\"outline-link-H13\">Secondary causes</a><ul><li><a href=\"#H14\" id=\"outline-link-H14\">- Estrogen deficiency</a></li><li><a href=\"#H15\" id=\"outline-link-H15\">- Drugs</a></li><li><a href=\"#H16\" id=\"outline-link-H16\">- Other</a></li></ul></li><li><a href=\"#H17\" id=\"outline-link-H17\">Normal pregnancy and lactation</a></li><li><a href=\"#H18\" id=\"outline-link-H18\">Pregnancy and lactation-associated osteoporosis</a></li><li><a href=\"#H19\" id=\"outline-link-H19\">Transient osteoporosis of the hip</a></li><li><a href=\"#H20\" id=\"outline-link-H20\">Idiopathic osteoporosis</a></li></ul></li><li><a href=\"#H1531222098\" id=\"outline-link-H1531222098\">SOCIETY GUIDELINE LINKS</a></li><li><a href=\"#H21\" id=\"outline-link-H21\">SUMMARY</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ENDO/2058|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=ENDO/64403\" class=\"graphic graphic_table\">- Secondary causes of osteoporosis in premenopausal women</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=bone-disease-with-hyperthyroidism-and-thyroid-hormone-therapy\" class=\"medical medical_review\">Bone disease with hyperthyroidism and thyroid hormone therapy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-features-and-evaluation-of-glucocorticoid-induced-osteoporosis\" class=\"medical medical_review\">Clinical features and evaluation of glucocorticoid-induced osteoporosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-turner-syndrome\" class=\"medical medical_review\">Clinical manifestations and diagnosis of Turner syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-evaluation-of-hyperprolactinemia\" class=\"medical medical_review\">Clinical manifestations and evaluation of hyperprolactinemia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-diagnosis-and-evaluation-of-osteoporosis-in-postmenopausal-women\" class=\"medical medical_review\">Clinical manifestations, diagnosis, and evaluation of osteoporosis in postmenopausal women</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cystic-fibrosis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Cystic fibrosis: Clinical manifestations and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=drugs-that-affect-bone-metabolism\" class=\"medical medical_review\">Drugs that affect bone metabolism</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=eating-disorders-overview-of-epidemiology-clinical-features-and-diagnosis\" class=\"medical medical_review\">Eating disorders: Overview of epidemiology, clinical features, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-and-etiology-of-osteoporosis-in-men\" class=\"medical medical_review\">Epidemiology and etiology of osteoporosis in men</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=evaluation-and-treatment-of-premenopausal-osteoporosis\" class=\"medical medical_review\">Evaluation and treatment of premenopausal osteoporosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=functional-hypothalamic-amenorrhea-pathophysiology-and-clinical-manifestations\" class=\"medical medical_review\">Functional hypothalamic amenorrhea: Pathophysiology and clinical manifestations</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\" class=\"medical medical_review\">Management of spontaneous primary ovarian insufficiency (premature ovarian failure)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=metabolic-bone-disease-in-inflammatory-bowel-disease\" class=\"medical medical_review\">Metabolic bone disease in inflammatory bowel disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=osteogenesis-imperfecta-clinical-features-and-diagnosis\" class=\"medical medical_review\">Osteogenesis imperfecta: Clinical features and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-dual-energy-x-ray-absorptiometry\" class=\"medical medical_review\">Overview of dual-energy x-ray absorptiometry</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-stress-fractures\" class=\"medical medical_review\">Overview of stress fractures</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-the-management-of-osteoporosis-in-postmenopausal-women\" class=\"medical medical_review\">Overview of the management of osteoporosis in postmenopausal women</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathogenesis-of-osteoporosis\" class=\"medical medical_review\">Pathogenesis of osteoporosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathogenesis-epidemiology-and-clinical-manifestations-of-celiac-disease-in-adults\" class=\"medical medical_review\">Pathogenesis, epidemiology, and clinical manifestations of celiac disease in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=primary-hyperparathyroidism-clinical-manifestations\" class=\"medical medical_review\">Primary hyperparathyroidism: Clinical manifestations</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=risk-factors-for-calcium-stones-in-adults\" class=\"medical medical_review\">Risk factors for calcium stones in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-osteoporosis\" class=\"medical medical_society_guidelines\">Society guideline links: Osteoporosis</a></li></ul></div></div>","javascript":null}